SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-042855
Filing Date
2023-11-28
Accepted
2023-11-28 08:45:18
Documents
14
Period of Report
2023-11-28
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48829
2 ex3-1.htm EX-3.1 13023
  Complete submission text file 0001493152-23-042855.txt   285068

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cing-20231128.xsd EX-101.SCH 3781
4 XBRL DEFINITION FILE cing-20231128_def.xml EX-101.DEF 26635
5 XBRL LABEL FILE cing-20231128_lab.xml EX-101.LAB 36734
6 XBRL PRESENTATION FILE cing-20231128_pre.xml EX-101.PRE 25259
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5327
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40874 | Film No.: 231442000
SIC: 2834 Pharmaceutical Preparations